Matthew Caufield Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Matthew Caufield

Stock Analyst at HC Wainwright & Co.

(3.7)
# 2396
Out of 5,474 analysts
171
Total ratings
Success rate
Average return
26 Stocks
Name Action PT Current % Upside Ratings Updated
MLYS Mineralys Therapeuti...
Reiterates: Buy
42 42
38.5 9.09% 11 Sep 8, 2025
KOD Kodiak Sciences
Maintains: Neutral
3 5
10.06 -50.3% 5 Aug 18, 2025
DMAC DiaMedica Therapeuti...
Reiterates: Buy
12 12
7.21 66.44% 7 Aug 15, 2025
LYRA Lyra Therapeutics
Reiterates: Neutral
16 16
6.96 129.89% 9 Aug 14, 2025
FBLG FibroBiologics
Maintains: Strong Buy
10 12
0.54 2122.22% 5 Aug 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
48 56
39.89 40.39% 7 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
1.36 488.24% 4 Jun 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
10
6.56 52.44% 1 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
12.89 55.16% 10 Jun 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
8
3 166.67% 1 Jun 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 2
n/a n/a 9 May 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
72
56.49 27.46% 1 May 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
9 9
9.6 -6.25% 8 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
5.76 73.61% 13 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
21.84 37.36% 3 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
3.47 764.55% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32 32
11.71 173.27% 3 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.86 1062.79% 4 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
2 2
2.1 -4.76% 6 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12 2
3.41 -41.35% 7 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
2 2
9.02 -77.83% 16 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
36 36
6.97 416.5% 18 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
1.17 1438.46% 9 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28
368.95 -92.41% 1 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
35 40
39.95 0.13% 6 May 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
11.17 79.05% 1 Jul 18, 2022